🇺🇸 FDA
Patent

US 10363294

Yeast-brachyury immunotherapeutic compositions

granted A61KA61K2039/51A61K2039/545

Quick answer

US patent 10363294 (Yeast-brachyury immunotherapeutic compositions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/51, A61K2039/545, A61K2039/55511, A61K2039/6006